Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gian Paolo Tonini

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Genes & Molecular Sequences

Living Beings

Infant

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Neoplasm Staging

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gemignani Federica; Neri Monica; Bottari Fabio; Barale Roberto; Canessa Pier Aldo; Canzian Federico; Ceppi Marcello; Spitaleri Irene; Cipollini Monica; Ivaldi Gian Paolo; Mencoboni Manlio; Scaruffi Paola; Tonini Gian Paolo; Ugolini Donatella; Mutti Luciano; Bonassi Stefano; Landi Stefano
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.
Perfumo Chiara; Parodi Stefano; Mazzocco Katia; Defferrari Raffaella; Inga Alberto; Scarrà Giovanna Bianchi; Ghiorzo Paola; Haupt Riccardo; Tonini Gian Paolo; Fronza Gilberto
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma.
Albino Domenico; Scaruffi Paola; Moretti Stefano; Coco Simona; Truini Mauro; Di Cristofano Claudio; Cavazzana Andrea; Stigliani Sara; Bonassi Stefano; Tonini Gian Paolo
Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gian Paolo Tonini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gemignani Federica; Neri Monica; Bottari Fabio; Barale Roberto; Canessa Pier Aldo; Canzian Federico; Ceppi Marcello; Spitaleri Irene; Cipollini Monica; Ivaldi Gian Paolo; Mencoboni Manlio; Scaruffi Paola; Tonini Gian Paolo; Ugolini Donatella; Mutti Luciano; Bonassi Stefano; Landi Stefano
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.
Mutation research 2009;671(1-2):76-83.
2009: Perfumo Chiara; Parodi Stefano; Mazzocco Katia; Defferrari Raffaella; Inga Alberto; Scarrà Giovanna Bianchi; Ghiorzo Paola; Haupt Riccardo; Tonini Gian Paolo; Fronza Gilberto
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma.
Pediatric blood & cancer 2009;53(4):576-83.
2008: Albino Domenico; Scaruffi Paola; Moretti Stefano; Coco Simona; Truini Mauro; Di Cristofano Claudio; Cavazzana Andrea; Stigliani Sara; Bonassi Stefano; Tonini Gian Paolo
Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
Cancer 2008;113(6):1412-22.
2008: Cattelani Sara; Defferrari Raffaella; Marsilio Sonia; Bussolari Rita; Candini Olivia; Corradini Francesca; Ferrari-Amorotti Giovanna; Guerzoni Clara; Pecorari Luisa; Menin Chiara; Bertorelle Roberta; Altavista Pierluigi; McDowell Heather P; Boldrini Renata; Dominici Carlo; Tonini Gian Paolo; Raschellà Giuseppe; Calabretta Bruno
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3248-53.
2008: De Bernardi Bruno; Gambini Claudio; Haupt Riccardo; Granata Claudio; Rizzo Antonino; Conte Massimo; Tonini Gian Paolo; Bianchi Maurizio; Giuliano Maria; Luksch Roberto; Prete Arcangelo; Viscardi Elisabetta; Garaventa Alberto; Sementa Angela Rita; Bruzzi Paolo; Angelini Paola
Retrospective study of childhood ganglioneuroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1710-6.
2007: Defferrari Raffaella; Tonini Gian Paolo; Conte Massimo; Papio Filippo; Sementa Angela Rita; Valent Alexander; Schena Francesca; Perri Patrizia; Mazzocco Katia
Concomitant DDX1 and MYCN gain in neuroblastoma.
Cancer letters 2007;256(1):56-63.
2007: Scaruffi Paola; Coco Simona; Cifuentes Francisco; Albino Domenico; Nair Manoj; Defferrari Raffaella; Mazzocco Katia; Tonini Gian Paolo
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
Cancer genetics and cytogenetics 2007;177(1):20-9.
2007: Landi Stefano; Gemignani Federica; Neri Monica; Barale Roberto; Bonassi Stefano; Bottari Fabio; Canessa Pier Aldo; Canzian Federico; Ceppi Marcello; Filiberti Rosangela; Ivaldi Gian Paolo; Mencoboni Manlio; Scaruffi Paola; Tonini Gian Paolo; Mutti Luciano; Puntoni Riccardo
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma.
International journal of cancer. Journal international du cancer 2007;120(12):2739-43.
2007: De Ambrosis Alessandro; Casciano Ida; Croce Michela; Pagnan Gabriella; Radic Luana; Banelli Barbara; Di Vinci Angela; Allemanni Giorgio; Tonini Gian Paolo; Ponzoni Mirco; Romani Massimo; Ferrini Silvano
An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells.
International journal of cancer. Journal international du cancer 2007;120(1):39-47.
2007: Longo Luca; Panza Emanuele; Schena Francesca; Seri Marco; Devoto Marcella; Romeo Giovanni; Bini Carla; Pappalardo Giuseppe; Tonini Gian Paolo; Perri Patrizia
Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p.
Human heredity 2007;63(3-4):205-11.
2005: Coco Simona; Defferrari Raffaella; Scaruffi Paola; Cavazzana Andrea; Di Cristofano Claudio; Longo Luca; Mazzocco Katia; Perri Patrizia; Gambini Claudio; Moretti Stefano; Bonassi Stefano; Tonini Gian Paolo
Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
The Journal of pathology 2005;207(3):346-57.
2005: Scaruffi Paola; Valent Alexander; Schramm Alexander; Astrahantseff Kathy; Eggert Angelika; Tonini Gian Paolo
Application of microarray-based technology to neuroblastoma.
Cancer letters 2005;228(1-2):13-20.
2005: Longo Luca; Tonini Gian Paolo; Ceccherini Isabella; Perri Patrizia
Oligogenic inheritance in neuroblastoma.
Cancer letters 2005;228(1-2):65-9.
2005: Banelli Barbara; Gelvi Ilaria; Di Vinci Angela; Scaruffi Paola; Casciano Ida; Allemanni Giorgio; Bonassi Stefano; Tonini Gian Paolo; Romani Massimo
Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.
Oncogene 2005;24(36):5619-28.
2005: Lanciotti Marina; Coco Simona; Michele Paola Di; Haupt Riccardo; Boni Luca; Pigullo Simona; Dufour Carlo; Garaventa Alberto; Tonini Gian Paolo
Glutathione S-transferase polymorphisms and susceptibility to neuroblastoma.
Pharmacogenetics and genomics 2005;15(6):423-6.
2005: Perri Patrizia; Bachetti Tiziana; Longo Luca; Matera Ivana; Seri Marco; Tonini Gian Paolo; Ceccherini Isabella
PHOX2B mutations and genetic predisposition to neuroblastoma.
Oncogene 2005;24(18):3050-3.
2005: Uccini Stefania; Mannarino Olga; McDowell Heather P; Pauser Ursula; Vitali Roberta; Natali Pier Giorgio; Altavista Pierluigi; Andreano Tiziana; Coco Simona; Boldrini Renata; Bosco Sandro; Clerico Anna; Cozzi Denis; Donfrancesco Alberto; Inserra Alessandro; Kokai George; Losty Paul D; Nicotra Maria R; Raschellà Giuseppe; Tonini Gian Paolo; Dominici Carlo
Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):380-9.
2004: Corrias Maria Valeria; Faulkner Lawrence B; Pistorio Angela; Rosanda Cristina; Callea Francesco; Piccolo Maria Serena Lo; Scaruffi Paola; Marchi Cinzia; Lacitignola Laura; Occhino Marzia; Gambini Claudio; Tonini Gian Paolo; Haupt Riccardo; De Bernardi Bruno; Pistoia Vito; Garaventa Alberto
Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7978-85.
2004: Scaruffi Paola; Parodi Stefano; Mazzocco Katia; Defferrari Raffaella; Fontana Vincenzo; Bonassi Stefano; Tonini Gian Paolo
Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 2004;8(2):93-100.
2003: Romani M; Tonini G P; Banelli B; Allemanni G; Mazzocco K; Scaruffi P; Boni L; Ponzoni M; Pagnan G; Raffaghello L; Ferrini S; Croce M; Casciano I
Biological and clinical role of p73 in neuroblastoma.
Cancer letters 2003;197(1-2):111-7.
2003: Tonini Gian Paolo; Romani Massimo
Genetic and epigenetic alterations in neuroblastoma.
Cancer letters 2003;197(1-2):69-73.
2003: Tonini Gian Paolo; Longo Luca; Coco Simona; Perri Patrizia
Familial neuroblastoma: a complex heritable disease.
Cancer letters 2003;197(1-2):41-5.
2003: Gambini Claudio; Conte Massimo; Bernini Gabriella; Angelini Paola; Pession Andrea; Paolucci Paolo; Donfrancesco Alberto; Veneselli Edvige; Mazzocco Katia; Tonini Gian Paolo; Raffaghello Lizzia; Dominici Carlo; Morando Adriana; Negri Francesca; Favre Anna; De Bernardi Bruno; Pistoia Vito
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.
Virchows Archiv : an international journal of pathology 2003;442(6):555-62.
2003: Origone Paola; Defferrari Raffaella; Mazzocco Katia; Lo Cunsolo Crocifissa; De Bernardi Bruno; Tonini Gian Paolo
Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma.
American journal of medical genetics. Part A 2003;118A(4):309-13.
2003: De Bernardi Bruno; Nicolas Brigitte; Boni Luca; Indolfi Paolo; Carli Modesto; Cordero Di Montezemolo Luca; Donfrancesco Alberto; Pession Andrea; Provenzi Massimo; di Cataldo Andrea; Rizzo Antonino; Tonini Gian Paolo; Dallorso Sandro; Conte Massimo; Gambini Claudio; Garaventa Alberto; Bonetti Federico; Zanazzo Andrea; D'Angelo Paolo; Bruzzi Paolo;
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1592-601.
2002: Perri Patrizia; Longo Luca; Cusano Roberto; McConville Carmel M; Rees Sally A; Devoto Marcella; Conte Massimo; Ferrara Giovanni Battista; Seri Marco; Romeo Giovanni; Tonini Gian Paolo
Weak linkage at 4p16 to predisposition for human neuroblastoma.
Oncogene 2002;21(54):8356-60.
2002: Garaventa A; Boni L; Lo Piccolo M S; Tonini G P; Gambini C; Mancini A; Tonegatti L; Carli M; di Montezemolo L C; Di Cataldo A; Casale F; Mazzocco K; Cecchetto G; Rizzo A; Bernardi B;
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):956-64.
2002: Perri Patrizia; Longo Luca; McConville Carmel; Cusano Roberto; Rees Sally A; Seri Marco; Conte Massimo; Romeo Giovanni; Devoto Marcella; Tonini Gian Paolo
Linkage analysis in families with recurrent neuroblastoma.
Annals of the New York Academy of Sciences 2002;963():74-84.
2002: Giordani Lucia; Iolascon Achille; Servedio Veronica; Mazzocco Katia; Longo Luca; Tonini Gian Paolo
Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors.
Cancer genetics and cytogenetics 2002;135(1):42-7.
2002: Casciano I; Banelli B; Croce M; Allemanni G; Ferrini S; Tonini G P; Ponzoni M; Romani M
Role of methylation in the control of DeltaNp73 expression in neuroblastoma.
Cell death and differentiation 2002;9(3):343-5.
2002: Casciano I; Mazzocco K; Boni L; Pagnan G; Banelli B; Allemanni G; Ponzoni M; Tonini G P; Romani M
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients.
Cell death and differentiation 2002;9(3):246-51.
2001: Lo Cunsolo C; Casciano I; Gambini C; De Bernardi B; Tonini G P; Romani M
Molecular alterations in a case of bilateral adrenal neuroblastoma.
Medical and pediatric oncology 2001;36(4):491-3.
2001: Orlando C; Raggi C C; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini G P; Pazzagli M; Serio M; Maggi M
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
Medical and pediatric oncology 2001;36(1):224-6.
2001: Tonini G P; McConville C; Cusano R; Rees S A; Dagnino M; Longo L; De Bernardi B; Conte M; Garaventa A; Romeo G; Devoto M; Seri M
Exclusion of candidate genes and chromosomal regions in familial neuroblastoma.
International journal of molecular medicine 2001;7(1):85-9.
2000: Cunsolo C L; Bicocchi M P; Petti A R; Tonini G P
Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
British journal of cancer 2000;83(10):1295-300.
2000: Raggi C C; Maggi M; Renzi D; Calabrò A; Bagnoni M L; Scaruffi P; Tonini G P; Pazzagli M; De Bernardi B; Bernini G; Serio M; Orlando C
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
The Journal of clinical endocrinology and metabolism 2000;85(10):3866-73.
2000: Iolascon A; Giordani L; Borriello A; Carbone R; Izzo A; Tonini G P; Gambini C; Della Ragione F
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas.
British journal of cancer 2000;82(6):1171-6.
2000: Scaruffi P; Casciano I; Masiero L; Basso G; Romani M; Tonini G P
Lack of p73 expression in mature B-ALL and identification of three new splicing variants restricted to pre B and C-ALL indicate a role of p73 in B cell ALL differentiation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(3):518-9.
2000: Borriello A; Pietra V D; Criscuolo M; Oliva A; Tonini G P; Iolascon A; Zappia V; Ragione F D
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.
Oncogene 2000;19(1):51-60.
1999: Raggi C C; Bagnoni M L; Tonini G P; Maggi M; Vona G; Pinzani P; Mazzocco K; De Bernardi B; Pazzagli M; Orlando C
Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system.
Clinical chemistry 1999;45(11):1918-24.
1999: Romani M; Scaruffi P; Casciano I; Mazzocco K; Lo Cunsolo C; Cavazzana A; Gambini C; Boni L; De Bernardi B; Tonini G P
Stage-independent expression and genetic analysis of tp73 in neuroblastoma.
International journal of cancer. Journal international du cancer 1999;84(4):365-9.
1999: Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini G P; De Bernardi B; Calabretta B
Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Cancer research 1999;59(14):3365-8.
1999: Casciano I; Ponzoni M; Lo Cunsolo C; Tonini G P; Romani M
Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma.
Cell death and differentiation 1999;6(5):391-3.
1999: Scaruffi P; Cusano R; Dagnino M; Tonini G P
Detection of DNA polymorphisms and point mutations of high-affinity nerve growth factor receptor (TrkA) in human neuroblastoma.
International journal of oncology 1999;14(5):935-8.
1999: Lo Cunsolo C; Iolascon A; Cavazzana A; Cusano R; Strigini P; Mazzocco K; Giordani L; Massimo L; De Bernardi B; Conte M; Tonini G P
Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development.
Cancer genetics and cytogenetics 1999;109(2):126-30.
1998: Iolascon A; Lo Cunsolo C; Giordani L; Cusano R; Mazzocco K; Boumgartner M; Ghisellini P; Faienza M F; Boni L; De Bernardi B; Conte M; Romeo G; Tonini G P
Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.
Cancer letters 1998;130(1-2):83-92.
1998: Iolascon A; Giordani L; Moretti A; Tonini G P; Lo Cunsolo C; Mastropietro S; Borriello A; Ragione F D
Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma.
Pediatric research 1998;43(1):139-44.
1998: Lo Cunsolo C; Casciano I; Banelli B; Tonini G P; Romani M
Refined chromosomal localization of the putative tumor suppressor gene TP73.
Cytogenetics and cell genetics 1998;82(3-4):199-201.
1997: Tonini G P; Lo Cunsolo C; Cusano R; Iolascon A; Dagnino M; Conte M; Milanaccio C; De Bernardi B; Mazzocco K; Scaruffi P
Loss of heterozygosity for chromosome 1p in familial neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1953-6.
1997: Perri P; Pession A; Mazzocco K; Scaruffi P; Strigini P; Iolascon A; Albergoni M P; Basso G; Tonini G P
Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1949-52.
1997: Tonini G P; Mazzocco K; di Vinci A; Geido E; de Bernardi B; Giaretti W
Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors.
Journal of neuro-oncology 1997;31(1-2):209-15.
1997: Tonini G P; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):85-93.
1996: Corrias M V; Scaruffi P; Occhino M; De Bernardi B; Tonini G P; Pistoia V
Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma.
International journal of cancer. Journal international du cancer 1996;69(5):403-7.
1996: Perri P; Pession A; Mazzocco K; Strigini P; Iolascon A; Basso G; Tonini G P
Peculiar allelotype associated with susceptibility to neuroblastoma.
Genes, chromosomes & cancer 1996;17(1):60-3.
1995: Bonfiglio A; Parodi M T; Tonini G P
Subcellular details of early events of differentiation induced by retinoic acid in human neuroblastoma cells detected by atomic force microscope.
Experimental cell research 1995;216(1):73-9.
1995: Tonini G P; Fabretti G; Kuznicki J; Massimo L; Scaruffi P; Brisigotti M; Mazzocco K
Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):499-504.
1994: Bottini F; Mazzocco K; Abbondi T; Tonini G P
Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation.
Neuroscience letters 1994;181(1-2):35-8.
1994: Tonini G P; Mazzocco K; Scaruffi P
[Oncogenes and suppressor genes in the genesis and progression of solid tumors in children]
La Pediatria medica e chirurgica : Medical and surgical pediatrics 1994;16(3):203-9.
1993: Fabbretti G; Valenti C; Loda M; Brisigotti M; Cozzutto C; Tonini G P; Callea F
N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma).
Human pathology 1993;24(3):294-7.
1993: Tonini G P
Neuroblastoma: a multiple biological disease.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):802-4.
1992: Corrias M V; Tonini G P
An oligomer complementary to the 5' end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells.
Anticancer research 1992;12(5):1431-8.
1992: Stenger A M; Garré M L; Andreussi L; Cama A; Callea F; Brisigotti M; Fabbretti G; Di Martino D; Tonini G P
Expression of histone H3 cell cycle-related gene, vimentin and MYC genes in pediatric brain tumors. A preliminary analysis showing the different malignant cell growth potential.
Brain research. Molecular brain research 1992;13(3):273-5.
1991: Stenger A M; Garrè M L; Cama A; Andreussi L; Brisigotti M; Tonini G P; Cornaglia-Ferraris P
N-myc oncogene amplification in a pediatric case of glioblastoma multiforme.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 1991;7(7):410-3.
1991: Sansone R; Strigini P; Badiali M; Dominici C; Fontana V; Iolascon A; De Bernardi B; Tonini G P
Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience.
Cancer genetics and cytogenetics 1991;54(2):253-7.
1991: Marazzi L; Parodi M T; Di Martino D; Ferrari S; Tonini G P
Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
Anticancer research 1991;11(2):947-52.
1991: Tonini G P; Parodi M T; Di Martino D; Varesio L
Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid.
FEBS letters 1991;280(2):221-4.
1991: Tonini G P; Casalaro A; Cara A; Di Martino D
Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines.
Cancer research 1991;51(6):1733-7.
1991: Corrias M V; Di Martino D; Tonini G P; Cornaglia-Ferraris P
N-myc and MDR1 expression are mutually exclusive in NB tumors at onset.
Progress in clinical and biological research 1991;366():77-83.
1991: Sansone R; Di Martino D; Lanino E; Dini G; Massimo L; Tonini G P
MYCN amplification does not affect survival of neuroblastoma patients treated with autologous bone marrow transplantation.
Bone marrow transplantation 1991;7 Suppl 3():133-5.
1990: Parodi M T; Varesio L; Tonini G P
The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages.
FEBS letters 1990;269(1):4-6.
1990: Di Martino D; Avignolo C; Marsano B; Di Vinci A; Cara A; Giaretti W; Tonini G P
Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell line.
Cancer letters 1990;52(2):101-6.
1990: Tonini G P; Cornaglia-Ferraris P; Fontana V; Strigini P; Sansone R
Prognostic significance of N-myc amplification in neuroblastoma.
Clinical chemistry 1990;36(7):1392-3.
1990: Corrias M V; Cornaglia-Ferraris P; Di Martino D; Stenger A M; Lanino E; Boni L; Tonini G P
Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
Anticancer research 1990;10(4):897-902.
1990: Cornaglia-Ferraris P; Sansone R; Mariottini G L; Longo L; Tonini G P
Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line.
International journal of cancer. Journal international du cancer 1990;45(3):578-9.
1990: Cornaglia-Ferraris P; Ponzoni M; Montaldo P; Mariottini G L; Donti E; Di Martino D; Tonini G P
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-myc.
Pediatric research 1990;27(1):1-6.
1989: Parodi M T; Varesio L; Tonini G P
Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines.
Cancer chemotherapy and pharmacology 1989;25(2):114-6.
1988: Donti E; Longo L; Tonini G P; Verdona G; Melodia A; Lanino E; Cornaglia-Ferraris P
Cytogenetic and molecular study of two human neuroblastoma cell lines.
Cancer genetics and cytogenetics 1988;30(2):225-31.
1988: Sansone R; Tonini G P; Cornaglia-Ferraris P
[Activation of cellular N-myc oncogene in neuroblastoma]
La Clinica terapeutica 1988;124(4):269-78.
1988: Parodi M T; Tonini G P; Bologna R; Franchini E; Cornaglia-Ferraris P
Cisplatin-induced erythroid differentiation in K562 cells: modulation of transferrin receptor.
Bollettino dell'Istituto sieroterapico milanese 1988;67(2):142-8.
1987: Tonini G P; Verdona G; Devoto M; Sansone R; Cornaglia-Ferraris P
N-myc oncogene amplification and catecholamine metabolism in patients with neuroblastoma.
Lancet 1987;2(8562):795.
1987: Tonini G P; Verdona G; Garaventa A; Cornaglia-Ferraris P
Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
Anticancer research 1987;7(4B):729-32.
1987: Tonini G P; Verdona G; De Bernardi B; Sansone R; Massimo L; Cornaglia-Ferraris P
N-myc oncogene amplification in a patient with IV-S neuroblastoma.
The American journal of pediatric hematology/oncology 1987;9(1):8-10.
1986: Tonini G P; Sansone R; Verdona G; Massimo L; Cornaglia-Ferraris P
[Oncogenes and neoplasms in children: hemo-lymphoproliferative diseases. II]
Minerva pediatrica 1986;38(19):813-8.
1986: Tonini G P; Sansone R; Verdona G; Massimo L; Cornaglia-Ferraris P
[Oncogenes and neoplasms in children: solid tumors. I]
Minerva pediatrica 1986;38(17-18):727-33.
1986: Verdona G; Garaventa A; Coviello D A; Cornaglia-Ferraris P; Tonini G P
[Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers]
Bollettino dell'Istituto sieroterapico milanese 1986;65(4):304-8.
1986: Tonini G P; Parodi M T; Bologna R; Persici P; Cornaglia-Ferraris P
Cisplatin induces modulation of transferrin receptor during cellular differentiation in vitro.
Cancer chemotherapy and pharmacology 1986;18(1):92.
1986: Verdona G; Garaventa A; Coviello D A; Sansone R; Cornaglia-Ferraris P; Tonini G P
Does N-myc amplification correlate with other prognostic factors in advanced neuroblastoma? Preliminary results.
Pediatric hematology and oncology 1986;3(4):367-9.
1985: Ponzoni M; Fenice M; Montaldo P; Tonini G P; Cornaglia-Ferraris P
[In vitro synthesis of interleukin 2 (IL-2) by T lymphocytes extracted from a lymphoepithelial thymoma. Purification and biochemical characterization]
Bollettino dell'Istituto sieroterapico milanese 1985;64(1):12-24.
1982: Pasino M; Bellone M; Cornaglia P; Tonini G P; Massimo L
Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin.
Journal of immunopharmacology 1982;4(1-2):101-8.
1981: Pasino M; Bellone M; Cornaglia Ferraris P; Tonini G P; Massimo L
Methisoprinol effect on enriched B and T lymphocyte populations stimulated with phytohemagglutinin.
Bollettino dell'Istituto sieroterapico milanese 1981;60(4):297-301.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Gian Paolo Tonini

Research Profile (preview)

Disorders

Physiology

Genes & Molecular Sequences

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Gian Paolo Tonini (preview)

All Publications